Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why Elbit Systems Stock Is Sliding Today

Elbit Systems Ltd (NASDAQ:ESLT) reported first-quarter FY22 revenue growth of 21% year-over-year to $1.35 billion, with a significant part of the growth being organic, in addition to the contribution of Sparton. Adjusted gross margin declined 100 bps to 24.6%. Adjusted operating margin contracted to 4.9% from 8.3% in 1Q21. Adjusted EPS fell to…

Nvidia Announces New Liquid-Cooled GPUs: How It Will Double Data Center Computing Power

Nvidia Announces New Liquid-Cooled GPUs: How It Will Double Data Center Computing Power

Nvidia Corporation (NASDAQ: NVDA) made a splash with its announcements at "Computex 2022," that is currently underway in Taiwan.

Activision Blizzard Employees Proceed Towards Unionization

Activision Blizzard Employees Proceed Towards Unionization

Twenty-two quality-assurance testers at Activision Blizzard, Inc (NASDAQ:ATVI) studios have voted in favor of unionizing with the Communications Workers of America, the Wall Street Journal reports. The workers took part in the vote at Middleton, Wisconsin-based Raven, on May 23 amid opposition from Activision management. The move followed years of complaints about excessive…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Petco Shares Are Gaining Today

Petco Health And Wellness Company Inc (NASDAQ:WOOF) reported first-quarter FY22 sales growth of 4.3% year-on-year, to $1.48 billion, beating the consensus of $1.46 billion. Comparable sales growth was 5.1%. The gross profit rose 2% Y/Y to $607.7 million with a margin of 41.2%. Selling, general and administrative expenses increased 2% to $557.7 million.…

Where Cytokinetics Stands With Analysts

Within the last quarter, Cytokinetics (NASDAQ:CYTK) has observed the following analyst ratings:

Why Zoom Shares Are Rising Today

Zoom Video Communications Inc (NASDAQ: ZM) shares are trading higher Tuesday morning after the company reported better-than-expected financial results and issued guidance above analyst estimates.

FDA Lifts Partial Hold On Alpine Immune's Davoceticept Combo Trial In Advanced Cancer

The FDA has removed the partial clinical hold placed on Alpine Immune Sciences Inc's (NASDAQ:ALPN) NEON-2 trial of davoceticept (ALPN-202) in advanced malignancies. Davoceticept is a first-in-class conditional CD28 costimulator and a dual checkpoint inhibitor. The partial clinical hold was prompted by Alpine's report of patient death in the NEON-2 trial. The trial is evaluating davoceticept…

inkl

Read news from The Economist, FT, and more,
with one subscription

Fintech Spotlight: FTX Floating Acquisitions Of Webull, Apex And Public.com

Fresh after CEO Sam Bankman-Fried disclosed a stake in Robinhood Markets Inc (NASDAQ: HOOD), FTX reportedly is in talks regarding acquisitions with large firms including Webull, Public.com, and Apex Clearing.

Expect More Musk-Related Fireworks At Twitter Shareholder Meeting This Week: Wedbush Analyst

Expect More Musk-Related Fireworks At Twitter Shareholder Meeting This Week: Wedbush Analyst

Twitter Inc’s (NASDAQ: TWTR) special meeting with shareholders on Wednesday is expected to kick off some more fireworks between Tesla Inc (NASDAQ: TSLA) CEO Elon Musk and the micr

TENX: 1Q:22 Financial and Operational Review

By John Vandermosten, CFA NASDAQ:TENX READ THE FULL TENX RESEARCH REPORT

Why SpringWorks Shares Are Soaring Today Premarket

Why SpringWorks Shares Are Soaring Today Premarket

SpringWorks Therapeutics Inc (NASDAQ: SWTX) has announced positive topline results from the DeFi Phase 3 trial evaluating nirogacestat in adult patients with progressing desmoid tumors.

The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures

The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures

Here's a roundup of top developments in the biotech space over the last 24 hours:

Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg

Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg

Dexcom Inc (NYSE:DXCM) is reportedly in talks to acquire medical-device company Insulet Corporation (NASDAQ: PODD) to create a giant in diabetes devices, according to people with knowledge of the matter. According to Bloomberg, talks between the companies are ongoing, and an agreement could be reached in the coming weeks. Discussions could still be delayed or fall…

Morning Brief: Top Financial Stories Dominating on Tuesday, May 24

Morning Brief: Top Financial Stories Dominating on Tuesday, May 24

Get all your
news in one place.

100's of premium titles.
One news app.

Canadian Solar Misses Q1 Revenue Amid Challenging Operating Environment

Canadian Solar Inc (NASDAQ:CSIQ) reported first-quarter FY22 revenue growth of 15% year-on-year to $1.25 billion, missing the consensus of $1.31 billion. Higher solar shipment volumes and ASP and a significant increase in the battery storage solutions business drove the growth. Solar module shipments of 3.63 GW, up 42% Y/Y, were in line with…

Recap: Petco Health and Wellness Q1 Earnings

Petco Health and Wellness (NASDAQ:WOOF) reported its Q1 earnings results on Tuesday, May 24, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Recap: Ituran Location & Control Q1 Earnings

Ituran Location & Control (NASDAQ:ITRN) reported its Q1 earnings results on Tuesday, May 24, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Recap: Canadian Solar Q1 Earnings

Canadian Solar (NASDAQ:CSIQ) reported its Q1 earnings results on Tuesday, May 24, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100's of premium titles.
One news app.

10 Biggest Price Target Changes For Tuesday

Needham reduced WalkMe Ltd. (NASDAQ: WKME) price target from $40 to $20. WalkMe shares dropped 8.1% to close at $12.20 on Monday.

iMedia Brands Clocks 37% Top-Line Growth In Q1; Reiterates FY22 Outlook

iMedia Brands Inc (NASDAQ:IMBI) reported first-quarter FY22 sales growth of 37% year-on-year to $154.5 million, marginally beating the consensus of $154.44 million. Total 12-month rolling active customers grew by 48% Y/Y, driven by the continued strong customer growth from Christopher & Banks and the addition of the 123tv customer file. The gross margin…

Instagram Undergoes Visual Refresh: Here Are The Details

True to the adage "necessity is the mother of all invention," the necessity to stay alive in the competitive race has led Meta Platforms, Inc.'s (NASDAQ: FB) Instagram app to do a makeover.

Tesla Bull Cathie Wood Says Bet Against 'Disruptive Innovation' Will Prove Ill-informed, Ill-timed

Popular stock picker Cathie Wood, who runs Ark Investment Management, said on Monday the current bet against disruptive innovation will prove as ill-informed and ill-timed as the tech and telecom bubble in the late 1990s.

Amazon Shareholders Seek To Question Pay, Tax, Working Conditions in CEO Andy Jassy's First Annual Meet

Amazon.com Inc (NASDAQ: AMZN) shareholders look to challenge its executive pay, tax transparency, working conditions, and unionization as CEO Andy Jassy faces his first annual meeting,

Who Can Beat Tesla On EV Sales? This Company CEO Believes So

Volkswagen AG (OTC:VWAGY) CEO Herbert Diess said Volkswagen can overtake Tesla, Inc. (NASDAQ:TSLA) as the world’s largest seller of electric vehicles by 2025, CNBC reported. Stabilizing supply chain woes would help the German carmaker to increase production in the coming months, the CEO said. He expects some relief from the semiconductor supply market to…

Esports Entertainment Q3 Top-Line Miss Street View, Cuts FY22 Revenue Outlook

Esports Entertainment Group Inc (NASDAQ:GMBL) reported third-quarter FY22 sales growth of 190.8% year-on-year, to $15.7 million, missing the consensus of $16.86 million. The gross profit rose 203.2% Y/Y to $9.4 million and the profit margin for the quarter expanded by 500 basis points to 60%. The operating loss for the quarter expanded to…

1 … 461 462 463 464

People

Sam Bankman-Fried

John Vandermosten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

367,112 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play